(Thanks to Israel21c) Israel’s RedHill Biopharma is to perform advanced clinical trials of a once-a-day drug, code-named RHB-102, to prevent nausea and vomiting – often a side effect of chemotherapy and radiation therapy for cancer. Current medication for this purpose … Continue reading →